On 22 September 2026 Maple Leaf Foods said it would wind down its plant-protein plants in Seattle, Washington and Turners Falls, Massachusetts, and consolidate US production at Indianapolis. Chief executive Curtis Frank gave the reason in one sentence: “declining volumes have left our manufacturing network substantially underutilized.”
The plant that survives is the one Maple Leaf bought in January 2021 to add capacity. Its own release then described a 118,000-square-foot Indianapolis plant with an initial capacity of about 4.5 million kilograms, an estimated cost of US$100 million and roughly 115 jobs at full operation. Five years and one demand collapse later, that plant is the last one standing, and the company that told the market in 2021 it needed “incremental capacity” is telling them in 2026 that three plants at current utilization are “not sustainable”.
This piece lays the two announcements side by side, flags a tenfold discrepancy in how the 2021 capacity was reported, and lists what the 2026 announcement does not tell operators, suppliers and equipment buyers.
What was announced
The company release says the transition will run “in phases over approximately 12 to 18 months, with targeted completion in Q4 2027”, and that production continues at Seattle and Turners Falls in the meantime. It frames the decision as part of its Fuel for Growth initiative and says the expected benefits, costs and capital requirements “are included in Maple Leaf Foods’ previously disclosed 2030 financial outlook”. It says the company expects to invest in Indianapolis and add team members there, and calls the recent relaunch of Yves Veggie Cuisine “complementary to this strategy”. Green Queen quotes the fuller line as “bringing a leading brand and additional volume into our portfolio”. Food Business News adds that Yves was relaunched in Canada on 14 September 2026 with five new products.
The trade coverage agrees on what is not in the release. vegconomist reports that Maple Leaf “has not disclosed how many jobs are affected, the size of the Indianapolis investment or the savings it expects”. Just Food reports the same on jobs, and adds that the company will consider opportunities at other facilities where feasible.
| Site | What it makes (per Green Queen) | Headcount reported by Green Queen | Fate |
|---|---|---|---|
| Seattle, WA | Meat-free sausages, deli slices, burgers and roasts for Field Roast and Lightlife | 120 | Wind down by Q4 2027 |
| Turners Falls, MA | Tempeh, Smart Bacon, Smart Dogs, ground, sausage and deli alternatives | 120 to 150 | Wind down by Q4 2027 |
| Indianapolis, IN | Tempeh; company site calls it “the largest tempeh manufacturing site in the world” | 54 (Green Queen, citing the company website) | Survives; investment and hiring expected |
Practical consequence: the headcounts are Green Queen’s, not the company’s release, and they say nothing about how many jobs the closures remove. Treat them as scale indicators only.
What Maple Leaf said about Indianapolis in 2021
The company’s 11 January 2021 release announced the purchase of a 118,000-square-foot Indianapolis plant with “initial capacity of approximately 4.5 million kilograms”. It put the cost of the project, “including the acquisition cost”, at about US$100 million, and said that “when fully operational it will employ approximately 115 people”. The plant offered “flexibility” for a second phase “which could include doubling the capacity”. Initial production was targeted for the first half of 2022. The release notes that in 2019 the company had announced plans for a new plant protein facility in nearby Shelbyville, Indiana.
Our arithmetic on those numbers: US$100 million over 4.5 million kilograms of initial annual capacity is roughly $22 per kilogram of annual capacity. That includes the acquisition, so it is not a build-cost benchmark, and we have not seen a breakdown between purchase and fit-out.
A tenfold discrepancy. Food Dive reported on 13 January 2021 that the plant “will have an initial production capacity of about 99.2 million pounds of tempeh”. That is about 45 million kilograms, ten times the company’s own 4.5 million. Food Manufacturing carries the 4.5 million kilogram figure. We use the company’s release, and note that 4.5 million kilograms is about 9.9 million pounds, which suggests Food Dive misplaced a decimal. Anyone quoting Indianapolis capacity from the trade press should check which figure they have.
How the growth case unwound
Maple Leaf has told the same story in steps.
In August 2021, Food Business News reported the company expected plant-based profitability in 2023 to 2024, citing plant protein sales of C$211 million in fiscal 2020, up 20%, and a target of 30% sales growth in the second half of 2021.
In August 2022, the company reduced the size of its Greenleaf Foods plant-based protein division by 25%. Chief executive Michael McCain said: “This transformational outcome did not materialize.” He described “sizing the shoe to fit a new foot”. The same report says the $100 million Indiana tempeh project was continuing.
In February 2024, Maple Leaf merged its meat and plant protein businesses. vegconomist reports plant protein sales fell 13.2% in 2023, and that adjusted EBITDA improved to neutral or better in the second half of that year.
In September 2026 it is closing two of the three US plants. The two closing sites are older than the survivor: Green Queen says Seattle launched in 1997 and Turners Falls has been Lightlife’s site since 1998, while Indianapolis was acquired in 2021 and began production in 2022.
What the group numbers do and do not say
Just Food reports that in the quarter to the end of June 2026, Maple Leaf’s sales rose 1.6% to C$1.02 billion and adjusted EBITDA rose 4.8% to C$137.1 million, and that full-year guidance was reaffirmed at mid-single-digit revenue growth and adjusted EBITDA of C$520 million to C$540 million. It also reports that prepared foods, which includes plant-based protein, saw sales fall 2% on “lower volumes and higher trade promotion spending”.
That is the extent of what we found. The Q2 2026 results release we read reports two segments, poultry and prepared foods, with no plant protein line. Since the 2024 merger the company does not appear to report plant protein sales, EBITDA, volumes or utilization separately. So the claim at the centre of the decision, that the network is “substantially underutilized”, cannot be checked against any number Maple Leaf publishes.
The counter-argument
The case that this is unremarkable is strong. Consolidating three plants into one to fix utilization is what a manufacturer does when volume falls, and it is arguably the responsible option. The company says its commitment to the category is unchanged, and it is a profitable group. It is putting more into Indianapolis, not exiting, and it is bringing Yves volume in. If demand for tempeh and meat alternatives stabilizes, a single well-utilized plant beats three half-empty ones.
The other side of it is arithmetic. A plant bought for roughly 115 jobs and a possible doubling of capacity now reports 54 employees on the company’s website, according to Green Queen, and is expected to absorb output from two plants that together reportedly employ roughly 240 to 270 people. Whether Indianapolis has the capacity to take Seattle’s and Turners Falls’ volumes without new capital is not stated. The company says it expects to invest, but has not said how much.
Practical consequence: for a co-manufacturer or supplier, the useful read is that US plant-protein volume is consolidating into one owner-operated site with headroom, which reduces the outsourced capacity Maple Leaf would need and raises the chance that two plants’ worth of equipment and floor space reaches the market in 2027. We cover the price of one such lot in our piece on Meati’s 300,000 litres. Whether Maple Leaf sells, leases or redeploys the Seattle and Turners Falls assets is not stated.
Related coverage: a WARN notice that arrived after the fact, the two consolidation counts that diverge, and NotCo’s four market exits.
What we could not establish
- Utilization. No figure for current utilization at any of the three plants, or the level Maple Leaf considers sustainable.
- Jobs affected. The company has not said how many jobs the closures remove. The headcounts in the table are Green Queen’s and may not be current.
- Investment and savings. The Indianapolis investment, the cost of closure and the expected savings are described only as included in the 2030 outlook, with no figures.
- Indianapolis capacity today. Whether the plant is running at 4.5 million kilograms, whether phase two was ever built, and how much of the volume from the other plants it can absorb.
- Which products move. The company release does not say which brands or products are made at which site, and we have not confirmed Green Queen’s product lists.
- Fate of the closing sites and equipment. No sale, lease or redeployment plan is stated.
- Plant protein sales. We found no separately reported plant protein sales for 2025 or 2026. The Q2 2026 group figures include the whole prepared foods segment.
- The 2021 capacity discrepancy. We have relied on the company release for 4.5 million kilograms. We have not seen the original Food Dive source for 99.2 million pounds.
What to watch
- Whether Maple Leaf attaches a dollar figure to the Indianapolis investment, in a filing or on an earnings call.
- Whether the Q4 2027 completion date holds, or the transition stretches.
- Any Seattle or Turners Falls asset sale, lease or auction, and its price.
- Whether Maple Leaf resumes separate reporting of plant protein sales or volumes. That would make the utilization claim testable.
- Whether the phase two doubling at Indianapolis, floated in 2021, resurfaces as a stated plan or is dropped.